Zimmer Biomet Holdings Inc - Company Profile
Powered by 
All the data and insights you need on Zimmer Biomet Holdings Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Zimmer Biomet Holdings Inc Strategy Report
- Understand Zimmer Biomet Holdings Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company that focuses on musculoskeletal healthcare. The company designs manufacture and markets orthopedic reconstructive products; biologics, sports medicine, extremities, and trauma products; suite of integrated digital and robotic technologies; craniomaxillofacial and thoracic products; office-based technologies; and associated surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries of bones, joints, and supporting soft tissues. Zimmer Biomet offers products to orthopedic surgeons, neurosurgeons, other specialists, stocking distributors, hospitals, healthcare dealers, and healthcare purchasing organizations. The company markets its products through direct sales channels and distributors in the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.
Headquarters
United States of America
Address
345 E Main St, Warsaw, Indiana, 46580-2746
Website
www.zimmerbiomet.com/en
Telephone
1 574 2676131
No of Employees
18,000
Industry
Medical Equipment
Ticker Symbol & Exchange
ZBH (NYSE)
Revenue (2022)
$7.4B
6.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
342.5%
(2022 vs 2021)
Market Cap*
$25.6B
Net Profit Margin (2022)
XYZ
315.9%
(2022 vs 2021)
* As of and is in US$
Zimmer Biomet Holdings Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | AdVent |
| Knee Replacement | Alloclassic (Zweymuller) |
| Complete Knee Solution | Avenir Complete |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Regulatory Approval | In February, the company received approval from the U.S. Food and Drug Administration for the ROSA Shoulder System for robotic-assisted shoulder replacement surgery. |
| 2023 | Contracts/Agreements | In August, the company entered into an agreement with Enernet Global to provide low carbon energy from a new trigeneration system at their manufacturing facility in Ponce. |
| 2023 | Corporate Changes/Expansions | In June, the company opened an expanded office and APAC global business services center in Kuala Lumpur, Malaysia. |
Competitor Comparison
| Key Parameters | Zimmer Biomet Holdings Inc | Medtronic Plc | Stryker Corp | DePuy Synthes Inc | Smith & Nephew Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Ireland | United States of America | United States of America | United Kingdom |
| City | Warsaw | Dublin | Kalamazoo | Warsaw | Watford |
| State/Province | Indiana | - | Michigan | Indiana | England |
| No. of Employees | 18,000 | 95,000 | 52,000 | 18,000 | 18,452 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Christopher B. Begley | Chairman | Executive Board | 2023 | 70 |
| Ivan Tornos | President; Chief Executive Officer; Director | Executive Board | 2023 | - |
| Suketu Upadhyay | Executive Vice President - Finance, Operations and Supply Chain; Chief Financial Officer | Senior Management | 2023 | - |
| Paul Stellato | Vice President; Chief Accounting Officer; Controller | Senior Management | 2022 | 48 |
| Rachel Ellingson | Senior Vice President; Chief Strategy Officer | Senior Management | 2018 | 53 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward